Summation Bio
Biotechnology
Summation Bio valuation and funding history | Last updated: April 4, 2022 | 1 funding rounds
Current Valuation
N/A
As of April 4, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$24.5M
Last Funding
Apr 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| April 4, 2022 | Early Stage VC (Series A) | $24.5M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Summation Bio is currently valued at N/A as of April 4, 2022.
What is Summation Bio Worth in 2026?
Summation Bio is a leading private company in the Biotechnology sector. Track Summation Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Summation Bio Valuation is Determined
Private company valuations like Summation Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.